{"listGrid":{"title":"Data sets, elements and combos paramaterized","subtitle":"This view should be used for custom for validation only.","headers":[{"name":"dataset","column":"dataset","type":"java.lang.String","hidden":false,"meta":false},{"name":"dataelement","column":"dataelement","type":"java.lang.String","hidden":false,"meta":false},{"name":"shortname","column":"shortname","type":"java.lang.String","hidden":false,"meta":false},{"name":"code","column":"code","type":"java.lang.String","hidden":false,"meta":false},{"name":"dataelementuid","column":"dataelementuid","type":"java.lang.String","hidden":false,"meta":false},{"name":"dataelementdesc","column":"dataelementdesc","type":"java.lang.String","hidden":false,"meta":false},{"name":"categoryoptioncombo","column":"categoryoptioncombo","type":"java.lang.String","hidden":false,"meta":false},{"name":"categoryoptioncombocode","column":"categoryoptioncombocode","type":"java.lang.String","hidden":false,"meta":false},{"name":"categoryoptioncombouid","column":"categoryoptioncombouid","type":"java.lang.String","hidden":false,"meta":false}],"metaData":{},"rowContext":{},"width":9,"rows":[["Host Country Targets: COP Prioritization SNU (USG) FY2024","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: HIV Known Status","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","DIAGNOSED_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","nF19GOjcnoD","","Female, Positive, <1","EK5V8gEHYPH","EK5V8gEHYPH"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: HIV Known Status","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","DIAGNOSED_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","nF19GOjcnoD","","Female, Positive, 10-14","RLGOV7MCVrF","RLGOV7MCVrF"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: HIV Known Status","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","DIAGNOSED_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","nF19GOjcnoD","","Female, Positive, 15-24","DeBA55gXcy3","DeBA55gXcy3"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: HIV Known Status","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","DIAGNOSED_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","nF19GOjcnoD","","Female, Positive, 1-9","jNtU64I1RaG","jNtU64I1RaG"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: HIV Known Status","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","DIAGNOSED_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","nF19GOjcnoD","","Female, Positive, 25-34","CeuDnHicKrF","CeuDnHicKrF"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: HIV Known Status","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","DIAGNOSED_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","nF19GOjcnoD","","Female, Positive, 35-49","SJyG6PfeF6l","SJyG6PfeF6l"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: HIV Known Status","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","DIAGNOSED_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","nF19GOjcnoD","","Female, Positive, 50+","JgmjEkK0toj","JgmjEkK0toj"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: HIV Known Status","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","DIAGNOSED_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","nF19GOjcnoD","","Male, Positive, <1","c0nenJ9EKQz","c0nenJ9EKQz"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: HIV Known Status","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","DIAGNOSED_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","nF19GOjcnoD","","Male, Positive, 10-14","SGNvThVISKr","SGNvThVISKr"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: HIV Known Status","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","DIAGNOSED_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","nF19GOjcnoD","","Male, Positive, 15-24","iJuMQQ1wnUf","iJuMQQ1wnUf"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: HIV Known Status","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","DIAGNOSED_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","nF19GOjcnoD","","Male, Positive, 1-9","S8DmkDGvfKA","S8DmkDGvfKA"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: HIV Known Status","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","DIAGNOSED_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","nF19GOjcnoD","","Male, Positive, 25-34","G5xBaxUTA1Q","G5xBaxUTA1Q"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: HIV Known Status","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","DIAGNOSED_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","nF19GOjcnoD","","Male, Positive, 35-49","IsCSXOSWFSn","IsCSXOSWFSn"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: HIV Known Status","DIAGNOSED_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","DIAGNOSED_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","nF19GOjcnoD","","Male, Positive, 50+","LOtNQ2NFIgT","LOtNQ2NFIgT"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","DIAGNOSED_SUBNAT (N, SUBNAT, HIVStatus/Sex) TARGET: HIV Known Status","DIAGNOSED_SUBNAT (N, SUBNAT, HIV/Sex) TARGET","DIAGNOSED_SUBNAT_N_SUBNAT_HIV_Sex_TARGET","xVPaflQHwEP","Number of people living with HIV who know their status","Female, Positive","ZgRwDPKsNN9","ZgRwDPKsNN9"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","DIAGNOSED_SUBNAT (N, SUBNAT, HIVStatus/Sex) TARGET: HIV Known Status","DIAGNOSED_SUBNAT (N, SUBNAT, HIV/Sex) TARGET","DIAGNOSED_SUBNAT_N_SUBNAT_HIV_Sex_TARGET","xVPaflQHwEP","Number of people living with HIV who know their status","Male, Positive","BMiKDDzrr49","BMiKDDzrr49"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","DIAGNOSED_SUBNAT (N, SUBNAT, HIVStatus) TARGET: HIV Known Status","DIAGNOSED_SUBNAT (N, SUBNAT, HIVStatus) TARGET","DIAGNOSED_SUBNAT_N_SUBNAT_HIVStatus_TARGET","mcDTjVP9B0e","Number of people living with HIV who know their status","Positive","LVcCRCAVjwj","LVcCRCAVjwj"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","KP_MAT_SUBNAT (N, SUBNAT, Sex) TARGET: PWID on MAT","KP_MAT_SUBNAT (N, SUBNAT, Sex) TARGET","KP_MAT_SUBNAT_N_SUBNAT_Sex_TARGET","ctGo7s0K63z","Number of people who inject drugs (PWID) on medication assisted therapy (MAT) for at least 6 months","Female","bHhcxwpICvc","bHhcxwpICvc"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","KP_MAT_SUBNAT (N, SUBNAT, Sex) TARGET: PWID on MAT","KP_MAT_SUBNAT (N, SUBNAT, Sex) TARGET","KP_MAT_SUBNAT_N_SUBNAT_Sex_TARGET","ctGo7s0K63z","Number of people who inject drugs (PWID) on medication assisted therapy (MAT) for at least 6 months","Male","pKlxpSVb56h","pKlxpSVb56h"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","KP_MAT_SUBNAT (N, SUBNAT) TARGET: PWID on MAT","KP_MAT_SUBNAT (N, SUBNAT) TARGET","KP_MAT_SUBNAT_N_SUBNAT_TARGET","CShdIv7wNUB","Number of people who inject drugs (PWID) on medication assisted therapy (MAT) for at least 6 months","default","default","HllvX50cXC0"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_ART_SUBNAT (D, SUBNAT, Age/Sex/HIVStatus) TARGET: ART","PMTCT_ART_SUBNAT (D, SUBNAT, Age/Sex/HIV) TARGET","PMTCT_ART_SUBNAT_D_SUBNAT_Age_Sex_HIV_TARGET","jaX3SUTcIki","Target Number and percentage of HIV-positive pregnant women who received antiretroviral medicine (ARV) during pregnancy to reduce the risk of mother-to-child transmission (SUBNAT)","Female, Positive, 10-14","AZaaTopriO2","AZaaTopriO2"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_ART_SUBNAT (D, SUBNAT, Age/Sex/HIVStatus) TARGET: ART","PMTCT_ART_SUBNAT (D, SUBNAT, Age/Sex/HIV) TARGET","PMTCT_ART_SUBNAT_D_SUBNAT_Age_Sex_HIV_TARGET","jaX3SUTcIki","Target Number and percentage of HIV-positive pregnant women who received antiretroviral medicine (ARV) during pregnancy to reduce the risk of mother-to-child transmission (SUBNAT)","Female, Positive, 15-24","BbEDCGwKcSF","BbEDCGwKcSF"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_ART_SUBNAT (D, SUBNAT, Age/Sex/HIVStatus) TARGET: ART","PMTCT_ART_SUBNAT (D, SUBNAT, Age/Sex/HIV) TARGET","PMTCT_ART_SUBNAT_D_SUBNAT_Age_Sex_HIV_TARGET","jaX3SUTcIki","Target Number and percentage of HIV-positive pregnant women who received antiretroviral medicine (ARV) during pregnancy to reduce the risk of mother-to-child transmission (SUBNAT)","Female, Positive, 25-34","BPUn17y407Y","BPUn17y407Y"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_ART_SUBNAT (D, SUBNAT, Age/Sex/HIVStatus) TARGET: ART","PMTCT_ART_SUBNAT (D, SUBNAT, Age/Sex/HIV) TARGET","PMTCT_ART_SUBNAT_D_SUBNAT_Age_Sex_HIV_TARGET","jaX3SUTcIki","Target Number and percentage of HIV-positive pregnant women who received antiretroviral medicine (ARV) during pregnancy to reduce the risk of mother-to-child transmission (SUBNAT)","Female, Positive, 35-49","ZCadUK0u2Ck","ZCadUK0u2Ck"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_ART_SUBNAT (D, SUBNAT, Age/Sex/HIVStatus) TARGET: ART","PMTCT_ART_SUBNAT (D, SUBNAT, Age/Sex/HIV) TARGET","PMTCT_ART_SUBNAT_D_SUBNAT_Age_Sex_HIV_TARGET","jaX3SUTcIki","Target Number and percentage of HIV-positive pregnant women who received antiretroviral medicine (ARV) during pregnancy to reduce the risk of mother-to-child transmission (SUBNAT)","Female, Positive, 50+","KC6IPmS3LYc","KC6IPmS3LYc"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_ART_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus/NewExistingArt) TARGET: ART","PMTCT_ART_SUBNAT (N, SUBNAT, A/S/HIV/Art) TARGET","PMTCT_ART_SUBNAT_N_SUBNAT_A_S_HIV_Art_TARGET","LvwJYdp0Jmr","Target Number and percentage of HIV-positive pregnant women who received antiretroviral medicine (ARV) during pregnancy to reduce the risk of mother-to-child transmission (SUBNAT)","Female, Positive, Life-long ART, Already, 10-14","fta0JtNlyWr","fta0JtNlyWr"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_ART_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus/NewExistingArt) TARGET: ART","PMTCT_ART_SUBNAT (N, SUBNAT, A/S/HIV/Art) TARGET","PMTCT_ART_SUBNAT_N_SUBNAT_A_S_HIV_Art_TARGET","LvwJYdp0Jmr","Target Number and percentage of HIV-positive pregnant women who received antiretroviral medicine (ARV) during pregnancy to reduce the risk of mother-to-child transmission (SUBNAT)","Female, Positive, Life-long ART, Already, 15-24","HjSoOWZgbMx","HjSoOWZgbMx"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_ART_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus/NewExistingArt) TARGET: ART","PMTCT_ART_SUBNAT (N, SUBNAT, A/S/HIV/Art) TARGET","PMTCT_ART_SUBNAT_N_SUBNAT_A_S_HIV_Art_TARGET","LvwJYdp0Jmr","Target Number and percentage of HIV-positive pregnant women who received antiretroviral medicine (ARV) during pregnancy to reduce the risk of mother-to-child transmission (SUBNAT)","Female, Positive, Life-long ART, Already, 25-34","hrbCVBqjija","hrbCVBqjija"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_ART_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus/NewExistingArt) TARGET: ART","PMTCT_ART_SUBNAT (N, SUBNAT, A/S/HIV/Art) TARGET","PMTCT_ART_SUBNAT_N_SUBNAT_A_S_HIV_Art_TARGET","LvwJYdp0Jmr","Target Number and percentage of HIV-positive pregnant women who received antiretroviral medicine (ARV) during pregnancy to reduce the risk of mother-to-child transmission (SUBNAT)","Female, Positive, Life-long ART, Already, 35-49","qjhg5HkcRE5","qjhg5HkcRE5"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_ART_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus/NewExistingArt) TARGET: ART","PMTCT_ART_SUBNAT (N, SUBNAT, A/S/HIV/Art) TARGET","PMTCT_ART_SUBNAT_N_SUBNAT_A_S_HIV_Art_TARGET","LvwJYdp0Jmr","Target Number and percentage of HIV-positive pregnant women who received antiretroviral medicine (ARV) during pregnancy to reduce the risk of mother-to-child transmission (SUBNAT)","Female, Positive, Life-long ART, Already, 50+","oTwR14S1qcf","oTwR14S1qcf"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_ART_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus/NewExistingArt) TARGET: ART","PMTCT_ART_SUBNAT (N, SUBNAT, A/S/HIV/Art) TARGET","PMTCT_ART_SUBNAT_N_SUBNAT_A_S_HIV_Art_TARGET","LvwJYdp0Jmr","Target Number and percentage of HIV-positive pregnant women who received antiretroviral medicine (ARV) during pregnancy to reduce the risk of mother-to-child transmission (SUBNAT)","Female, Positive, Life-long ART, New, 10-14","wUB2U7Sen6o","wUB2U7Sen6o"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_ART_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus/NewExistingArt) TARGET: ART","PMTCT_ART_SUBNAT (N, SUBNAT, A/S/HIV/Art) TARGET","PMTCT_ART_SUBNAT_N_SUBNAT_A_S_HIV_Art_TARGET","LvwJYdp0Jmr","Target Number and percentage of HIV-positive pregnant women who received antiretroviral medicine (ARV) during pregnancy to reduce the risk of mother-to-child transmission (SUBNAT)","Female, Positive, Life-long ART, New, 15-24","RhHqhPY2j2W","RhHqhPY2j2W"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_ART_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus/NewExistingArt) TARGET: ART","PMTCT_ART_SUBNAT (N, SUBNAT, A/S/HIV/Art) TARGET","PMTCT_ART_SUBNAT_N_SUBNAT_A_S_HIV_Art_TARGET","LvwJYdp0Jmr","Target Number and percentage of HIV-positive pregnant women who received antiretroviral medicine (ARV) during pregnancy to reduce the risk of mother-to-child transmission (SUBNAT)","Female, Positive, Life-long ART, New, 25-34","WNjKteoP1Av","WNjKteoP1Av"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_ART_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus/NewExistingArt) TARGET: ART","PMTCT_ART_SUBNAT (N, SUBNAT, A/S/HIV/Art) TARGET","PMTCT_ART_SUBNAT_N_SUBNAT_A_S_HIV_Art_TARGET","LvwJYdp0Jmr","Target Number and percentage of HIV-positive pregnant women who received antiretroviral medicine (ARV) during pregnancy to reduce the risk of mother-to-child transmission (SUBNAT)","Female, Positive, Life-long ART, New, 35-49","SR9hKxvt8vz","SR9hKxvt8vz"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_ART_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus/NewExistingArt) TARGET: ART","PMTCT_ART_SUBNAT (N, SUBNAT, A/S/HIV/Art) TARGET","PMTCT_ART_SUBNAT_N_SUBNAT_A_S_HIV_Art_TARGET","LvwJYdp0Jmr","Target Number and percentage of HIV-positive pregnant women who received antiretroviral medicine (ARV) during pregnancy to reduce the risk of mother-to-child transmission (SUBNAT)","Female, Positive, Life-long ART, New, 50+","MpaODCEKdbV","MpaODCEKdbV"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (D, SUBNAT, Age/Sex) TARGET: Known Results","PMTCT_STAT_SUBNAT (D, SUBNAT, Age/Sex) TARGET","PMTCT_STAT_SUBNAT_D_SUBNAT_Age_Sex_TARGET","jdFCj4dEvIK","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, 10-14","K6aPgqbrbhh","K6aPgqbrbhh"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (D, SUBNAT, Age/Sex) TARGET: Known Results","PMTCT_STAT_SUBNAT (D, SUBNAT, Age/Sex) TARGET","PMTCT_STAT_SUBNAT_D_SUBNAT_Age_Sex_TARGET","jdFCj4dEvIK","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, 15-24","QCqgJdAp5R4","QCqgJdAp5R4"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (D, SUBNAT, Age/Sex) TARGET: Known Results","PMTCT_STAT_SUBNAT (D, SUBNAT, Age/Sex) TARGET","PMTCT_STAT_SUBNAT_D_SUBNAT_Age_Sex_TARGET","jdFCj4dEvIK","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, 25-34","MeHh1HGwg0n","MeHh1HGwg0n"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (D, SUBNAT, Age/Sex) TARGET: Known Results","PMTCT_STAT_SUBNAT (D, SUBNAT, Age/Sex) TARGET","PMTCT_STAT_SUBNAT_D_SUBNAT_Age_Sex_TARGET","jdFCj4dEvIK","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, 35-49","XJH7o39LWF3","XJH7o39LWF3"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (D, SUBNAT, Age/Sex) TARGET: Known Results","PMTCT_STAT_SUBNAT (D, SUBNAT, Age/Sex) TARGET","PMTCT_STAT_SUBNAT_D_SUBNAT_Age_Sex_TARGET","jdFCj4dEvIK","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, 50+","hGOFA5WjwRK","hGOFA5WjwRK"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/KnownNewPosNewNeg) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/Stat) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_Stat_TARGET","thhkv2dmiuc","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, Known Positives, 10-14","FgFQzNUApeh","FgFQzNUApeh"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/KnownNewPosNewNeg) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/Stat) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_Stat_TARGET","thhkv2dmiuc","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, Known Positives, 15-24","dAySogrlCXQ","dAySogrlCXQ"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/KnownNewPosNewNeg) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/Stat) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_Stat_TARGET","thhkv2dmiuc","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, Known Positives, 25-34","CFh0Qj68FsZ","CFh0Qj68FsZ"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/KnownNewPosNewNeg) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/Stat) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_Stat_TARGET","thhkv2dmiuc","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, Known Positives, 35-49","SRQUW8X26ms","SRQUW8X26ms"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/KnownNewPosNewNeg) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/Stat) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_Stat_TARGET","thhkv2dmiuc","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, Known Positives, 50+","fmS8SI46bef","fmS8SI46bef"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/KnownNewPosNewNeg) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/Stat) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_Stat_TARGET","thhkv2dmiuc","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, Newly Tested Positives, 10-14","FGjeZwPXXwX","FGjeZwPXXwX"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/KnownNewPosNewNeg) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/Stat) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_Stat_TARGET","thhkv2dmiuc","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, Newly Tested Positives, 15-24","GCEvgu9Q3eu","GCEvgu9Q3eu"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/KnownNewPosNewNeg) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/Stat) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_Stat_TARGET","thhkv2dmiuc","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, Newly Tested Positives, 25-34","F3wn95cgE1Z","F3wn95cgE1Z"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/KnownNewPosNewNeg) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/Stat) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_Stat_TARGET","thhkv2dmiuc","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, Newly Tested Positives, 35-49","eUsGZNIEXzV","eUsGZNIEXzV"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/KnownNewPosNewNeg) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/Stat) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_Stat_TARGET","thhkv2dmiuc","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, Newly Tested Positives, 50+","Wo5W5msKnSl","Wo5W5msKnSl"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/KnownNewPosNewNeg) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/Stat) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_Stat_TARGET","thhkv2dmiuc","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, New Negatives, 10-14","s2Ct9dmwEbP","s2Ct9dmwEbP"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/KnownNewPosNewNeg) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/Stat) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_Stat_TARGET","thhkv2dmiuc","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, New Negatives, 15-24","nil7WOojNcU","nil7WOojNcU"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/KnownNewPosNewNeg) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/Stat) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_Stat_TARGET","thhkv2dmiuc","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, New Negatives, 25-34","YxOl2INB4tH","YxOl2INB4tH"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/KnownNewPosNewNeg) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/Stat) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_Stat_TARGET","thhkv2dmiuc","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, New Negatives, 35-49","gLooizzAAgz","gLooizzAAgz"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/KnownNewPosNewNeg) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex/Stat) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_Stat_TARGET","thhkv2dmiuc","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, New Negatives, 50+","e8RKx1RNM1H","e8RKx1RNM1H"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_TARGET","rJjmeacbvid","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, 10-14","K6aPgqbrbhh","K6aPgqbrbhh"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_TARGET","rJjmeacbvid","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, 15-24","QCqgJdAp5R4","QCqgJdAp5R4"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_TARGET","rJjmeacbvid","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, 25-34","MeHh1HGwg0n","MeHh1HGwg0n"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_TARGET","rJjmeacbvid","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, 35-49","XJH7o39LWF3","XJH7o39LWF3"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Known Results","PMTCT_STAT_SUBNAT (N, SUBNAT, Age/Sex) TARGET","PMTCT_STAT_SUBNAT_N_SUBNAT_Age_Sex_TARGET","rJjmeacbvid","Target Percentage of pregnant women with known HIV status (SUBNAT)","Female, 50+","hGOFA5WjwRK","hGOFA5WjwRK"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Receiving ART","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","TX_CURR_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","xghQXueYJxu","Target Percentage of adults and children receiving antiretroviral therapy (SUBNAT)","Female, Positive, <1","EK5V8gEHYPH","EK5V8gEHYPH"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Receiving ART","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","TX_CURR_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","xghQXueYJxu","Target Percentage of adults and children receiving antiretroviral therapy (SUBNAT)","Female, Positive, 10-14","RLGOV7MCVrF","RLGOV7MCVrF"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Receiving ART","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","TX_CURR_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","xghQXueYJxu","Target Percentage of adults and children receiving antiretroviral therapy (SUBNAT)","Female, Positive, 15-24","DeBA55gXcy3","DeBA55gXcy3"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Receiving ART","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","TX_CURR_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","xghQXueYJxu","Target Percentage of adults and children receiving antiretroviral therapy (SUBNAT)","Female, Positive, 1-9","jNtU64I1RaG","jNtU64I1RaG"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Receiving ART","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","TX_CURR_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","xghQXueYJxu","Target Percentage of adults and children receiving antiretroviral therapy (SUBNAT)","Female, Positive, 25-34","CeuDnHicKrF","CeuDnHicKrF"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Receiving ART","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","TX_CURR_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","xghQXueYJxu","Target Percentage of adults and children receiving antiretroviral therapy (SUBNAT)","Female, Positive, 35-49","SJyG6PfeF6l","SJyG6PfeF6l"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Receiving ART","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","TX_CURR_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","xghQXueYJxu","Target Percentage of adults and children receiving antiretroviral therapy (SUBNAT)","Female, Positive, 50+","JgmjEkK0toj","JgmjEkK0toj"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Receiving ART","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","TX_CURR_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","xghQXueYJxu","Target Percentage of adults and children receiving antiretroviral therapy (SUBNAT)","Male, Positive, <1","c0nenJ9EKQz","c0nenJ9EKQz"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Receiving ART","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","TX_CURR_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","xghQXueYJxu","Target Percentage of adults and children receiving antiretroviral therapy (SUBNAT)","Male, Positive, 10-14","SGNvThVISKr","SGNvThVISKr"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Receiving ART","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","TX_CURR_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","xghQXueYJxu","Target Percentage of adults and children receiving antiretroviral therapy (SUBNAT)","Male, Positive, 15-24","iJuMQQ1wnUf","iJuMQQ1wnUf"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Receiving ART","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","TX_CURR_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","xghQXueYJxu","Target Percentage of adults and children receiving antiretroviral therapy (SUBNAT)","Male, Positive, 1-9","S8DmkDGvfKA","S8DmkDGvfKA"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Receiving ART","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","TX_CURR_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","xghQXueYJxu","Target Percentage of adults and children receiving antiretroviral therapy (SUBNAT)","Male, Positive, 25-34","G5xBaxUTA1Q","G5xBaxUTA1Q"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Receiving ART","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","TX_CURR_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","xghQXueYJxu","Target Percentage of adults and children receiving antiretroviral therapy (SUBNAT)","Male, Positive, 35-49","IsCSXOSWFSn","IsCSXOSWFSn"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Receiving ART","TX_CURR_SUBNAT (N, SUBNAT, Age/Sex/HIV) TARGET","TX_CURR_SUBNAT_N_SUBNAT_Age_Sex_HIV_TARGET","xghQXueYJxu","Target Percentage of adults and children receiving antiretroviral therapy (SUBNAT)","Male, Positive, 50+","LOtNQ2NFIgT","LOtNQ2NFIgT"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","TX_CURR_SUBNAT (N, SUBNAT, Sex/HIVStatus) TARGET: Receiving ART","TX_CURR_SUBNAT (N, SUBNAT, Sex/HIV) TARGET","TX_CURR_SUBNAT_N_SUBNAT_Sex_HIV_TARGET","IwYoTvC2tof","Target Percentage of adults and children receiving antiretroviral therapy (SUBNAT)","Female, Positive","ZgRwDPKsNN9","ZgRwDPKsNN9"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","TX_CURR_SUBNAT (N, SUBNAT, Sex/HIVStatus) TARGET: Receiving ART","TX_CURR_SUBNAT (N, SUBNAT, Sex/HIV) TARGET","TX_CURR_SUBNAT_N_SUBNAT_Sex_HIV_TARGET","IwYoTvC2tof","Target Percentage of adults and children receiving antiretroviral therapy (SUBNAT)","Male, Positive","BMiKDDzrr49","BMiKDDzrr49"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","TX_CURR_SUBNAT (N, SUBNAT) TARGET: Receiving ART","TX_CURR_SUBNAT (N, SUBNAT) TARGET","TX_CURR_SUBNAT_N_SUBNAT_TARGET","qjBMdjQFy26","Number of adults and children currently receiving antiretroviral therapy (ART)","default","default","HllvX50cXC0"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/S/H) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_Age_S_H_TARGET","zoKiMGRucOY","Target Percentage of people living with HIV on ART with a suppressed viral load","Female, Positive, <1","EK5V8gEHYPH","EK5V8gEHYPH"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/S/H) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_Age_S_H_TARGET","zoKiMGRucOY","Target Percentage of people living with HIV on ART with a suppressed viral load","Female, Positive, 10-14","RLGOV7MCVrF","RLGOV7MCVrF"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/S/H) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_Age_S_H_TARGET","zoKiMGRucOY","Target Percentage of people living with HIV on ART with a suppressed viral load","Female, Positive, 15-24","DeBA55gXcy3","DeBA55gXcy3"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/S/H) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_Age_S_H_TARGET","zoKiMGRucOY","Target Percentage of people living with HIV on ART with a suppressed viral load","Female, Positive, 1-9","jNtU64I1RaG","jNtU64I1RaG"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/S/H) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_Age_S_H_TARGET","zoKiMGRucOY","Target Percentage of people living with HIV on ART with a suppressed viral load","Female, Positive, 25-34","CeuDnHicKrF","CeuDnHicKrF"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/S/H) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_Age_S_H_TARGET","zoKiMGRucOY","Target Percentage of people living with HIV on ART with a suppressed viral load","Female, Positive, 35-49","SJyG6PfeF6l","SJyG6PfeF6l"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/S/H) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_Age_S_H_TARGET","zoKiMGRucOY","Target Percentage of people living with HIV on ART with a suppressed viral load","Female, Positive, 50+","JgmjEkK0toj","JgmjEkK0toj"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/S/H) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_Age_S_H_TARGET","zoKiMGRucOY","Target Percentage of people living with HIV on ART with a suppressed viral load","Male, Positive, <1","c0nenJ9EKQz","c0nenJ9EKQz"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/S/H) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_Age_S_H_TARGET","zoKiMGRucOY","Target Percentage of people living with HIV on ART with a suppressed viral load","Male, Positive, 10-14","SGNvThVISKr","SGNvThVISKr"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/S/H) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_Age_S_H_TARGET","zoKiMGRucOY","Target Percentage of people living with HIV on ART with a suppressed viral load","Male, Positive, 15-24","iJuMQQ1wnUf","iJuMQQ1wnUf"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/S/H) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_Age_S_H_TARGET","zoKiMGRucOY","Target Percentage of people living with HIV on ART with a suppressed viral load","Male, Positive, 1-9","S8DmkDGvfKA","S8DmkDGvfKA"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/S/H) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_Age_S_H_TARGET","zoKiMGRucOY","Target Percentage of people living with HIV on ART with a suppressed viral load","Male, Positive, 25-34","G5xBaxUTA1Q","G5xBaxUTA1Q"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/S/H) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_Age_S_H_TARGET","zoKiMGRucOY","Target Percentage of people living with HIV on ART with a suppressed viral load","Male, Positive, 35-49","IsCSXOSWFSn","IsCSXOSWFSn"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/Sex/HIVStatus) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, Age/S/H) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_Age_S_H_TARGET","zoKiMGRucOY","Target Percentage of people living with HIV on ART with a suppressed viral load","Male, Positive, 50+","LOtNQ2NFIgT","LOtNQ2NFIgT"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, HIVStatus/Sex) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, HIV/Sex) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_HIV_Sex_TARGET","NgQE08Vyuxd","Target Percentage of people living with HIV on ART with a suppressed viral load","Female, Positive","ZgRwDPKsNN9","ZgRwDPKsNN9"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, HIVStatus/Sex) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, HIV/Sex) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_HIV_Sex_TARGET","NgQE08Vyuxd","Target Percentage of people living with HIV on ART with a suppressed viral load","Male, Positive","BMiKDDzrr49","BMiKDDzrr49"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, HIVStatus) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, HIV) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_HIV_TARGET","qXWRBZTRrUm","Target Percentage of people living with HIV on ART with a suppressed viral load","Positive","LVcCRCAVjwj","LVcCRCAVjwj"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, RoutineTargeted/HIVStatus) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, RT/HIV) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_RT_HIV_TARGET","f6xrgmTyQpi","Target Percentage of people living with HIV on ART with a suppressed viral load","Routine, Positive","gq5fsf6rOsT","gq5fsf6rOsT"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VL_SUPPRESSION_SUBNAT (N, SUBNAT, RoutineTargeted/HIVStatus) TARGET: Suppressed Viral Load","VL_SUPPRESSION_SUBNAT (N, SUBNAT, RT/HIV) TARGET","VL_SUPPRESSION_SUBNAT_N_SUBNAT_RT_HIV_TARGET","f6xrgmTyQpi","Target Percentage of people living with HIV on ART with a suppressed viral load","Targeted, Positive","NkXgw79M2ZT","NkXgw79M2ZT"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VMMC_CIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Voluntary Circumcised","VMMC_CIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET","VMMC_CIRC_SUBNAT_N_SUBNAT_Age_Sex_TARGET","SSun4i7nHlV","Target Number of males circumcised during the reporting period according to national standards (SUBNAT)","Male, <1","bqgzSxyznMk","bqgzSxyznMk"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VMMC_CIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Voluntary Circumcised","VMMC_CIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET","VMMC_CIRC_SUBNAT_N_SUBNAT_Age_Sex_TARGET","SSun4i7nHlV","Target Number of males circumcised during the reporting period according to national standards (SUBNAT)","Male, 10-14","PTDQF8Rn1PY","PTDQF8Rn1PY"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VMMC_CIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Voluntary Circumcised","VMMC_CIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET","VMMC_CIRC_SUBNAT_N_SUBNAT_Age_Sex_TARGET","SSun4i7nHlV","Target Number of males circumcised during the reporting period according to national standards (SUBNAT)","Male, 15-24","mekECTmX3PI","mekECTmX3PI"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VMMC_CIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Voluntary Circumcised","VMMC_CIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET","VMMC_CIRC_SUBNAT_N_SUBNAT_Age_Sex_TARGET","SSun4i7nHlV","Target Number of males circumcised during the reporting period according to national standards (SUBNAT)","Male, 1-9","Ozqm3BkJsOC","Ozqm3BkJsOC"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VMMC_CIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Voluntary Circumcised","VMMC_CIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET","VMMC_CIRC_SUBNAT_N_SUBNAT_Age_Sex_TARGET","SSun4i7nHlV","Target Number of males circumcised during the reporting period according to national standards (SUBNAT)","Male, 25-34","F7tVWi2xkLA","F7tVWi2xkLA"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VMMC_CIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Voluntary Circumcised","VMMC_CIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET","VMMC_CIRC_SUBNAT_N_SUBNAT_Age_Sex_TARGET","SSun4i7nHlV","Target Number of males circumcised during the reporting period according to national standards (SUBNAT)","Male, 35-49","eP36X3LAvm0","eP36X3LAvm0"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VMMC_CIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Voluntary Circumcised","VMMC_CIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET","VMMC_CIRC_SUBNAT_N_SUBNAT_Age_Sex_TARGET","SSun4i7nHlV","Target Number of males circumcised during the reporting period according to national standards (SUBNAT)","Male, 50+","Ish2YOKdtWr","Ish2YOKdtWr"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VMMC_CIRC_SUBNAT (N, SUBNAT, Sex) TARGET: Voluntary Circumcised","VMMC_CIRC_SUBNAT (N, SUBNAT, Sex) TARGET","VMMC_CIRC_SUBNAT_N_SUBNAT_Sex_TARGET","BLUT96oHPxO","Target Number of males circumcised during the reporting period according to national standards (SUBNAT)","Male","QXtyoEEa0I7","QXtyoEEa0I7"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VMMC_TOTALCIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Voluntary Circumcised","VMMC_TOTALCIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET","VMMC_TOTALCIRC_SUBNAT_N_SUBNAT_Age_Sex_TARGET","ZayJeEa6pCa","Target Total number of men ever circumcised","Male, <1","bqgzSxyznMk","bqgzSxyznMk"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VMMC_TOTALCIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Voluntary Circumcised","VMMC_TOTALCIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET","VMMC_TOTALCIRC_SUBNAT_N_SUBNAT_Age_Sex_TARGET","ZayJeEa6pCa","Target Total number of men ever circumcised","Male, 10-14","PTDQF8Rn1PY","PTDQF8Rn1PY"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VMMC_TOTALCIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Voluntary Circumcised","VMMC_TOTALCIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET","VMMC_TOTALCIRC_SUBNAT_N_SUBNAT_Age_Sex_TARGET","ZayJeEa6pCa","Target Total number of men ever circumcised","Male, 15-24","mekECTmX3PI","mekECTmX3PI"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VMMC_TOTALCIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Voluntary Circumcised","VMMC_TOTALCIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET","VMMC_TOTALCIRC_SUBNAT_N_SUBNAT_Age_Sex_TARGET","ZayJeEa6pCa","Target Total number of men ever circumcised","Male, 1-9","Ozqm3BkJsOC","Ozqm3BkJsOC"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VMMC_TOTALCIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Voluntary Circumcised","VMMC_TOTALCIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET","VMMC_TOTALCIRC_SUBNAT_N_SUBNAT_Age_Sex_TARGET","ZayJeEa6pCa","Target Total number of men ever circumcised","Male, 25-34","F7tVWi2xkLA","F7tVWi2xkLA"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VMMC_TOTALCIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Voluntary Circumcised","VMMC_TOTALCIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET","VMMC_TOTALCIRC_SUBNAT_N_SUBNAT_Age_Sex_TARGET","ZayJeEa6pCa","Target Total number of men ever circumcised","Male, 35-49","eP36X3LAvm0","eP36X3LAvm0"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VMMC_TOTALCIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET: Voluntary Circumcised","VMMC_TOTALCIRC_SUBNAT (N, SUBNAT, Age/Sex) TARGET","VMMC_TOTALCIRC_SUBNAT_N_SUBNAT_Age_Sex_TARGET","ZayJeEa6pCa","Target Total number of men ever circumcised","Male, 50+","Ish2YOKdtWr","Ish2YOKdtWr"],["Host Country Targets: COP Prioritization SNU (USG) FY2024","VMMC_TOTALCIRC_SUBNAT (N, SUBNAT, Sex) TARGET: Voluntary Circumcised","VMMC_TOTALCIRC_SUBNAT (N, SUBNAT, Sex) TARGET","VMMC_TOTALCIRC_SUBNAT_N_SUBNAT_Sex_TARGET","ywCrpZgX1P9","Target Total number of men ever circumcised","Male","QXtyoEEa0I7","QXtyoEEa0I7"]],"height":112,"headerWidth":9}}
